Skip to content

Clinical study on the efficacy of Fuyuan Xingnao Decoction in the treatment of cognitive impairment in the recovery period of stroke with wind-phlegm and blood stasis

Clinical study on the efficacy of Fuyuan Xingnao Decoction in the treatment of cognitive impairment in the recovery period of stroke with wind-phlegm and blood stasis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000578
Enrollment
Unknown
Registered
2025-03-24
Start date
2025-02-13
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke disease

Interventions

Treatment group: Western medicine basic treatment and rehabilitation physiotherapy + Fuyuan Xingnao Decoction
control group:Western medicine basic treatment and rehabilitation physiotherapy

Sponsors

Yichang Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients between 40 and 85 years of age; 2. It conforms to the wind-phlegm-blood stasis type in the recovery period of stroke in traditional Chinese medicine; 3. Meet the diagnostic criteria of western medicine for ischemic stroke; 4. Accompanied by different degrees of cognitive impairment 5. Transcranial CT/MRI evidence of intracranial infarction; 6. Onset time = 2 weeks; 7. The patient himself or the client signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Hemorrhagic stroke; 2. Acute phase of ischemic stroke; 3. Central system lesions such as brain trauma infection tumor and parasite; 4. Combined with severe organ dysfunction; Those who have participated in clinical trials of other drugs within 5.6 months; 6. Those who are allergic to the drugs in this study; 7. Poor compliance and inability to take drugs as prescribed.

Design outcomes

Primary

MeasureTime frame
Resting state fMRI imaging of the head;Montreal Cognitive Assessment (MoCA) Scale;National Institutes of Health Stroke Scale (NIHSS);

Secondary

MeasureTime frame
Barthel Index (BI);Pittsburgh Sleep Quality Index (PSQI) score;

Countries

China

Contacts

Public Contactanfeng xiang

Yichang Traditional Chinese Medicine Hospital

afxiang0101@163.com+86 159 7166 7172

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026